A detailed history of Silvercrest Asset Management Group LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 268,218 shares of TNDM stock, worth $9.94 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
268,218
Previous 269,765 0.57%
Holding current value
$9.94 Million
Previous $10.9 Million 4.64%
% of portfolio
0.08%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.21 - $47.3 $54,469 - $73,173
-1,547 Reduced 0.57%
268,218 $11.4 Million
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $8.21 Million - $14.4 Million
-269,765 Reduced 50.0%
269,765 $10.9 Million
Q2 2024

Aug 14, 2024

BUY
$30.43 - $53.43 $8.32 Million - $14.6 Million
273,372 Added 102.71%
539,530 $21.7 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $240,935 - $386,216
10,907 Added 4.27%
266,158 $9.42 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $2,556 - $5,554
179 Added 0.07%
255,251 $7.55 Million
Q3 2023

Nov 14, 2023

BUY
$19.33 - $36.22 $1.23 Million - $2.3 Million
63,373 Added 33.06%
255,072 $5.3 Million
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $679,337 - $1.19 Million
28,095 Added 17.17%
191,699 $4.7 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $822,484 - $1.07 Million
22,936 Added 16.31%
163,604 $6.64 Million
Q4 2022

Feb 14, 2023

SELL
$35.49 - $56.15 $76,977 - $121,789
-2,169 Reduced 1.52%
140,668 $6.32 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $2.44 Million - $3.85 Million
55,784 Added 64.08%
142,837 $6.84 Million
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $250,932 - $580,369
-4,715 Reduced 5.14%
87,053 $5.15 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $111,365 - $164,048
1,093 Added 1.21%
91,768 $10.7 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $64,644 - $83,805
547 Added 0.61%
90,675 $13.6 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $126,706 - $175,337
-1,355 Reduced 1.48%
90,128 $10.8 Million
Q2 2021

Aug 16, 2021

SELL
$77.0 - $100.19 $15,785 - $20,538
-205 Reduced 0.22%
91,483 $8.91 Million
Q1 2021

May 17, 2021

BUY
$81.28 - $104.34 $3.08 Million - $3.96 Million
37,951 Added 70.62%
91,688 $8.09 Million
Q4 2020

Feb 16, 2021

SELL
$86.4 - $121.75 $1.62 Million - $2.29 Million
-18,805 Reduced 25.92%
53,737 $5.14 Million
Q3 2020

Nov 16, 2020

SELL
$95.43 - $116.09 $118,046 - $143,603
-1,237 Reduced 1.68%
72,542 $8.23 Million
Q2 2020

Aug 14, 2020

SELL
$60.05 - $98.92 $37,471 - $61,726
-624 Reduced 0.84%
73,779 $7.3 Million
Q1 2020

May 15, 2020

BUY
$47.37 - $90.04 $3.52 Million - $6.7 Million
74,403 New
74,403 $4.79 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.